Bob Goeltz bolts Uni­ty Biotech­nol­o­gy to be­come CFO at Ar­cus Bio­sciences; John John­son tapped for his lat­est CEO gig

→ A press re­lease ear­li­er in the week not­ed that Bob Goeltz left his CFO post at Uni­ty Biotech­nol­o­gy “to pur­sue a new op­por­tu­ni­ty.” We now know what that op­por­tu­ni­ty is, join­ing Ter­ry Rosen’s crew at Ar­cus Bio­sciences as the new CFO. A for­mer ex­ec­u­tive di­rec­tor of cor­po­rate de­vel­op­ment at Am­gen, Goeltz was the CFO for Cy­tomX Ther­a­peu­tics be­fore mak­ing the move to an­ti-ag­ing start­up Uni­ty in 2017.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.